BOSAYA
NDC 83257-029, Denosumab-kyqq, injection, from Biocon Biologics Inc..
- Product NDC
- 83257-029
- Status
- Listed
- Labeler
- Biocon Biologics Inc.
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761436
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83257-029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DENOSUMAB60 mg/mL
Pharmacologic classes
RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83257-029-41 | 83257002941 | 1 SYRINGE in 1 CARTON (83257-029-41) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1e5e8c88-3c65-3076-e44b-02d92c2d343dMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=83257-029
Use it
Look up 83257-029 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83257-029 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83257-029. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.